https://www.selleckchem.com/pr....oducts/Bleomycin-sul
Target treatment using site-specific nanosystems is a hot topic for treating several diseases, especially cancer. The study was set out to develop site-specific liposomes using ConcanavalinA (ConA) to target β-lapachone(β-lap) to human breast cancer cells. Liposomes were prepared and characterized according to diameter size, zeta potential, ConA conjugation(%), and β-lap encapsulation efficiency (%). Isothermal Titration Calorimetry evaluated the binding energy between the biomolecules, which compose the liposomes. ConA avidit
Curtir
Comentario
Compartilhar
